<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T03:20:51Z</responseDate>
  <request identifier="oai:figshare.com:article/34021072" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34021072</identifier>
        <datestamp>2026-09-29T04:05:04Z</datestamp>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_69</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_133</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Dual-Selector Biphasic
Recognition Chiral Extraction
for Naproxen Enantiomers: Experimental Evaluation and Molecular-Level
Mechanism</dc:title>
          <dc:creator>Shuyuan Wen (25135078)</dc:creator>
          <dc:creator>Xiang Wei (1452547)</dc:creator>
          <dc:creator>Shengyuan Xu (543269)</dc:creator>
          <dc:creator>Hongye Cheng (1416415)</dc:creator>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Inorganic Chemistry</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Plant Biology</dc:subject>
          <dc:subject>two selectors generate</dc:subject>
          <dc:subject>quantum chemical calculations</dc:subject>
          <dc:subject>opposite recognition preferences</dc:subject>
          <dc:subject>bonding network near</dc:subject>
          <dc:subject>phase chiral selectors</dc:subject>
          <dc:subject>preferred aqueous selector</dc:subject>
          <dc:subject>complementary organic selector</dc:subject>
          <dc:subject>molecular dynamics simulations</dc:subject>
          <dc:subject>modified cavity entrance</dc:subject>
          <dc:subject>cd preferentially stabilizes</dc:subject>
          <dc:subject>organic phase</dc:subject>
          <dc:subject>aqueous phase</dc:subject>
          <dc:subject>selector concentrations</dc:subject>
          <dc:subject>water interface</dc:subject>
          <dc:subject>tartaric acid</dc:subject>
          <dc:subject>steric complementarity</dc:subject>
          <dc:subject>size matching</dc:subject>
          <dc:subject>results indicate</dc:subject>
          <dc:subject>naproxen enantiomers</dc:subject>
          <dc:subject>level mechanism</dc:subject>
          <dc:subject>hydrophilic hydroxyethyl</dc:subject>
          <dc:subject>feed concentration</dc:subject>
          <dc:subject>experimental evaluation</dc:subject>
          <dc:subject>enantiomeric separations</dc:subject>
          <dc:subject>enantiomeric excess</dc:subject>
          <dc:subject>directional hydrogen</dc:subject>
          <dc:subject>di -&lt;</dc:subject>
          <dc:subject>&gt;- toluoyl</dc:subject>
          <dc:subject>&gt;- naproxen</dc:subject>
          <dc:subject>93 %.</dc:subject>
          <dc:description>A dual-selector biphasic recognition chiral extraction
(BRCE) system
was developed for the resolution of racemic naproxen using hydrophobic l-di-&lt;i&gt;p&lt;/i&gt;-toluoyl-d-tartaric acid (L-DTTA)
in the organic phase and hydrophilic hydroxyethyl-β-cyclodextrin
(HE-β-CD) in the aqueous phase. Single-selector screening first
identified HE-β-CD as the preferred aqueous selector for &lt;i&gt;S&lt;/i&gt;-naproxen and L-DTTA as a complementary organic selector
for &lt;i&gt;R&lt;/i&gt;-naproxen. After optimization of selector concentrations,
feed concentration, pH and temperature, the single-stage enantioselectivity
yields 2.10, with an enantiomeric excess of 31.93%. Quantum chemical
calculations and molecular dynamics simulations were then used to
interpret the experimentally verified selectivity trends. The results
indicate that HE-β-CD preferentially stabilizes &lt;i&gt;S&lt;/i&gt;-naproxen through cavity-size matching and a directional hydrogen-bonding
network near the modified cavity entrance, whereas L-DTTA favors &lt;i&gt;R&lt;/i&gt;-naproxen through steric complementarity and extensive
van der Waals contacts. The opposite recognition preferences of the
two selectors generate a cooperative thermodynamic driving force across
the oil/water interface. This experimentally validated mechanism provides
criteria for selecting dual-phase chiral selectors and designing intensified
liquid–liquid extraction systems for enantiomeric separations.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.iecr.6c03193.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Dual-Selector_Biphasic_Recognition_Chiral_Extraction_for_Naproxen_Enantiomers_Experimental_Evaluation_and_Molecular-Level_Mechanism/34021072</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
